Forecasting immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor t-cell therapy

Forecasting immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor t-cell therapy

Background Immune effector cell-associated neurotoxicity syndrome (ICANS) is a clinical and neuropsychiatric syndrome that can occur days to weeks following administration chimeric antigen receptor (CAR) T-cell therapy. Manifestations of ICANS range from encephalopathy and aphasia to cerebral edema...

Full description

Bibliographic Details
Main Authors: Preeti Malik, Jorg Dietrich, M Brandon Westover, Daniel B Rubin, Jong Woo Lee, Yalda Amidi, Christine A Eckhardt, Syed A Quadri, Marcos Santana Firme, Daniel K Jones, Aayushee Jain, Husain H Danish, Caron A Jacobson, Sydney S Cash
Format: Article
Language:English
Published: BMJ Publishing Group 2022-11-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/10/11/e005459.full

Internet

https://jitc.bmj.com/content/10/11/e005459.full

Similar Items